To determine whether the interaction between Dsg2 and EGFR is relevant to skin cancer development, SCC tissues were immunostained for Dsg2 and EGFR, showing not only upregulation, but also co-localization, of Dsg2 and EGFR in these tissues in vivo (Figure 1). This evidence concerns the gene DSG2 and skin cancer.